Literature DB >> 8461547

Calcium enhances the bone-sparing effects of low-dosage estrogen in postmenopausal women.

B Ettinger1, H K Genant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461547     DOI： 10.1007/bf01621894

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  5 in total

1.  Low-dosage micronized 17 beta-estradiol prevents bone loss in postmenopausal women.

Authors:  B Ettinger; H K Genant; P Steiger; P Madvig
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

2.  Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures.

Authors:  J A Cauley; J P Gutai; L H Kuller; D LeDonne; R B Sandler; D Sashin; J G Powell
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

3.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

4.  Effect of estrone sulfate on postmenopausal bone loss.

Authors:  H K Genant; D J Baylink; J C Gallagher; S T Harris; P Steiger; M Herber
Journal:  Obstet Gynecol       Date:  1990-10       Impact factor: 7.661

5.  Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

Authors:  J C Gallagher; W T Kable; D Goldgar
Journal:  Am J Med       Date:  1991-02       Impact factor: 4.965
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.